Skip to content

Acute Uncomplicated Diverticulitis and Conservative Treatment: Accuracy of Inflammatory Indexes for Failure Prediction: Observational Prospective Cohort Study. (AUDRIP Trial)

Acute Uncomplicated Diverticulitis and Conservative Treatment: Accuracy of Inflammatory Indexes for Failure Prediction: Observational Prospective Cohort Study.

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05833698
Acronym
AUDRIP
Enrollment
2160
Registered
2023-04-27
Start date
2023-06-15
Completion date
2024-12-31
Last updated
2023-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Uncomplicated Diverticulitis

Brief summary

This is an observational multicenter study that will analyse the accuracy of inflammatory indexes as neutrophil-lymphocyte ratio and platelet-lymphocyte ratio, to predict the failure of conservative treatment of patients diagnosed of acute uncomplicated diverticulitis.

Interventions

DIAGNOSTIC_TESTElevation of NLR

Blood test

Sponsors

Fundación de Investigación Biomédica - Hospital Universitario de La Princesa
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Patients older than 18, diagnosed of acute uncomplicated diverticulitis. * Diagnosis made by CT or ultrasound

Exclusion criteria

* Patients younger than 18. * Patients diagnosed of acute complicated diverticulitis

Design outcomes

Primary

MeasureTime frame
Failure of conservative treatment with antibiotics15th june 2023-31st december 2024
Failure of conservative treatment without antibiotics15th june 2023-31st december 2024

Secondary

MeasureTime frame
Evaluate the accuracy of PLR and NLR as predictors of failure15th june 2023-31st december 2024
Analysis of trends in managemente of acute uncomplicated diverticulitis15th june 2023-31st december 2024

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026